Indraprastha Medical Corporation Ltd (INDRAMEDCO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 131877,
    "name": "Indrapr.Medical",
    "stock_name": "Indrapr.Medical",
    "full_name": "Indraprastha Medical Corporation Ltd",
    "name_url": "stocks-analysis/indraprmedical",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "387.60",
    "chg": 12.5,
    "chgp": "3.33%",
    "dir": 1,
    "prev_price": "375.10",
    "mcapval": "3,547.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532150,
    "symbol": "INDRAMEDCO",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE681B01017",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "5.13 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/indraprmedical-131877-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Indrapr.Medical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-overvalued-or-undervalued-3727273",
        "imagepath": "",
        "date": "2025-11-25 08:12:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Valuation Metrics Indicate Attractiveness</strong></p>\n<p>At a price-to-earnings (PE) ratio of approximately 26.8, Indrapr.Medical trades at a moderate valuation relative to its earnings. This figure is notably lower than many of its hospital sector peers, several of which command PE ratios well above 40 or even 70. The company’s price-to-book value stands at 7.12, reflecting a premium but not an excessive one given its strong return on equity (ROE) of 26.5% and return on capital employed (ROCE) exceeding 94%. These returns highlight efficient capital utilisation and profitability, justifying a valuation premium over book value.</p>\n<p>Enterprise value multiples further reinforce the stock’s appeal. The EV to EBITDA ratio of 16.5 is significantly more reasonable than competitors such as Max ..."
      },
      {
        "title": "Indraprastha Medical Corporation Valuation Shifts Highlight Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporations-valuation-turns-attractive-amid-market-volatility-3727246",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_valuationdot_3727246.png",
        "date": "2025-11-25 08:00:08",
        "description": "Indraprastha Medical Corporation’s recent valuation parameters indicate a notable shift in price attractiveness within the hospital sector, as key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios reflect a more favourable market assessment compared to historical and peer averages."
      },
      {
        "title": "Indraprastha Medical Corporation Sees Shift in Technical Momentum Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-sees-technical-momentum-shift-amid-mixed-market-signals-3723601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_technicaldot_3723601.png",
        "date": "2025-11-24 08:00:16",
        "description": "Indraprastha Medical Corporation, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a mild adjustment in the company’s evaluation metrics, with technical indicators presenting a mixed picture that warrants close attention from investors and market analysts alike."
      },
      {
        "title": "Is Indrapr.Medical technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-technically-bullish-or-bearish-3716876",
        "imagepath": "",
        "date": "2025-11-20 08:10:55",
        "description": "As of 19 November 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, while the daily moving averages also indicate a bullish trend. Although the Bollinger Bands show a mildly bullish signal on both weekly and monthly charts, the KST is bullish weekly but mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance against a bullish monthly view. Overall, the strength of the bullish trend is reinforced by the recent price movement, with the current price at 534.80, up from the previous close of 520.00...."
      },
      {
        "title": "Indraprastha Medical Corporation Shows Bullish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-technical-momentum-shifts-signal-bullish-outlook-3717070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_technicaldot_3717070.png",
        "date": "2025-11-20 08:00:22",
        "description": "Indraprastha Medical Corporation, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics. Recent evaluation adjustments highlight a transition towards a more bullish technical trend, supported by multiple indicators across daily, weekly, and monthly timeframes. This article analyses the current technical landscape, price movements, and comparative returns to provide a comprehensive view of the stock’s market position."
      },
      {
        "title": "Is Indrapr.Medical technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-technically-bullish-or-bearish-3713837",
        "imagepath": "",
        "date": "2025-11-19 08:14:18",
        "description": "As of 18 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the weekly and monthly MACD readings, which are both bullish. The Bollinger Bands also indicate a mildly bullish trend on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, while Dow Theory indicates a mildly bearish stance on the weekly but bullish on the monthly. The daily moving averages reflect a mildly bullish outlook. Overall, the indicators suggest a cautious bullish sentiment, tempered by some mixed signals in the longer time frames...."
      },
      {
        "title": "Is Indrapr.Medical overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-indraprmedical-overvalued-or-undervalued-3713559",
        "imagepath": "",
        "date": "2025-11-19 08:08:12",
        "description": "As of 18 November 2025, the valuation grade for Indrapr.Medical has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued. Key ratios include a PE ratio of 27.31, an EV to EBITDA of 16.83, and a PEG ratio of 1.50. \n\nIn comparison to its peers, Indrapr.Medical's valuation appears moderate, especially when compared to Max Healthcare, which is very expensive with a PE of 77.03, and Apollo Hospitals, which is attractive with a PE of 63.51. Notably, Indrapr.Medical has outperformed the Sensex over the past year with a return of 26.65% compared to the Sensex's 9.48%, reflecting its strong performance despite the recent grade change...."
      },
      {
        "title": "Indraprastha Medical Corporation Sees Adjustment in Evaluation on Technical and Valuation Parameters",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-downgraded-from-strong-buy-to-buy-by-marketsmojo-3714288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_mojoScore_3714288.png",
        "date": "2025-11-19 08:07:10",
        "description": "Indraprastha Medical Corporation, a key player in the hospital sector, has undergone a revision in its evaluation across multiple parameters, reflecting shifts in technical trends and valuation metrics. The company’s current market price stands at ₹520.60, with a market cap grade of 3, and recent trading has seen a day change of -5.07%. This article analyses the factors influencing the adjustment in its score grade, focusing on quality, valuation, financial trends, and technical indicators."
      },
      {
        "title": "Indraprastha Medical Corporation Technical Momentum Shifts Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-technical-momentum-shifts-amid-mixed-signals-3714080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/IndraprasthaMed_technicaldot_3714080.png",
        "date": "2025-11-19 08:00:28",
        "description": "Indraprastha Medical Corporation has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum amid recent market fluctuations. The stock’s current price stands at ₹520.60, down from the previous close of ₹548.40, marking a day change of -5.07%. This movement occurs within a broader context of mixed technical signals and evolving market dynamics."
      }
    ],
    "total": 378,
    "sid": "131877",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/indraprastha-medical-corporation-131877"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended 31-12-2025.",
      "datetime": "19-Jan-2026",
      "details": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve It is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 to consider and approve quarterly financial results for the quarter ended 31-12-2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jan-2026",
      "details": "Enclosed please find herewith a certificate dated 9/01/2026 issued by M/s MUFG Intime India Pvt Ltd registrar and share transfer agent of the company for the quarter ended 31/12/2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "19-Dec-2025",
      "details": "We wish to inform you that the trading window of the company will remain closed from 1st January 2026 till 48 hours after announcement / declaration of unaudited financial results for the quarter ending 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indraprastha Medical Corporation Ltd has declared <strong>45%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Indrapr.Medical overvalued or undervalued?

2025-11-25 08:12:29

Valuation Metrics Indicate Attractiveness At a price-to-earnings (PE) ratio of approximately 26.8, Indrapr.Medical trades at a moderate valuation relative to its earnings. This figure is notably lower than many of its hospital sector peers, several of which command PE ratios well above 40 or even 70. The company’s price-to-book value stands at 7.12, reflecting a premium but not an excessive one given its strong return on equity (ROE) of 26.5% and return on capital employed (ROCE) exceeding 94%. These returns highlight efficient capital utilisation and profitability, justifying a valuation premium over book value. Enterprise value multiples further reinforce the stock’s appeal. The EV to EBITDA ratio of 16.5 is significantly more reasonable than competitors such as Max ...

Indraprastha Medical Corporation Valuation Shifts Highlight Price Attractiveness

2025-11-25 08:00:08

Indraprastha Medical Corporation’s recent valuation parameters indicate a notable shift in price attractiveness within the hospital sector, as key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios reflect a more favourable market assessment compared to historical and peer averages.

Indraprastha Medical Corporation Sees Shift in Technical Momentum Amid Mixed Market Signals

2025-11-24 08:00:16

Indraprastha Medical Corporation, a key player in the hospital sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent market data reveals a mild adjustment in the company’s evaluation metrics, with technical indicators presenting a mixed picture that warrants close attention from investors and market analysts alike.

Is Indrapr.Medical technically bullish or bearish?

2025-11-20 08:10:55

As of 19 November 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, while the daily moving averages also indicate a bullish trend. Although the Bollinger Bands show a mildly bullish signal on both weekly and monthly charts, the KST is bullish weekly but mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance against a bullish monthly view. Overall, the strength of the bullish trend is reinforced by the recent price movement, with the current price at 534.80, up from the previous close of 520.00....

Indraprastha Medical Corporation Shows Bullish Momentum Amid Technical Shifts

2025-11-20 08:00:22

Indraprastha Medical Corporation, a key player in the hospital sector, has exhibited a notable shift in its technical momentum, reflecting evolving market dynamics. Recent evaluation adjustments highlight a transition towards a more bullish technical trend, supported by multiple indicators across daily, weekly, and monthly timeframes. This article analyses the current technical landscape, price movements, and comparative returns to provide a comprehensive view of the stock’s market position.

Is Indrapr.Medical technically bullish or bearish?

2025-11-19 08:14:18

As of 18 November 2025, the technical trend has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the weekly and monthly MACD readings, which are both bullish. The Bollinger Bands also indicate a mildly bullish trend on both weekly and monthly time frames. However, the KST shows a mixed signal with weekly bullishness and monthly mild bearishness, while Dow Theory indicates a mildly bearish stance on the weekly but bullish on the monthly. The daily moving averages reflect a mildly bullish outlook. Overall, the indicators suggest a cautious bullish sentiment, tempered by some mixed signals in the longer time frames....

Is Indrapr.Medical overvalued or undervalued?

2025-11-19 08:08:12

As of 18 November 2025, the valuation grade for Indrapr.Medical has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued. Key ratios include a PE ratio of 27.31, an EV to EBITDA of 16.83, and a PEG ratio of 1.50. In comparison to its peers, Indrapr.Medical's valuation appears moderate, especially when compared to Max Healthcare, which is very expensive with a PE of 77.03, and Apollo Hospitals, which is attractive with a PE of 63.51. Notably, Indrapr.Medical has outperformed the Sensex over the past year with a return of 26.65% compared to the Sensex's 9.48%, reflecting its strong performance despite the recent grade change....

Indraprastha Medical Corporation Sees Adjustment in Evaluation on Technical and Valuation Parameters

2025-11-19 08:07:10

Indraprastha Medical Corporation, a key player in the hospital sector, has undergone a revision in its evaluation across multiple parameters, reflecting shifts in technical trends and valuation metrics. The company’s current market price stands at ₹520.60, with a market cap grade of 3, and recent trading has seen a day change of -5.07%. This article analyses the factors influencing the adjustment in its score grade, focusing on quality, valuation, financial trends, and technical indicators.

Indraprastha Medical Corporation Technical Momentum Shifts Amid Market Volatility

2025-11-19 08:00:28

Indraprastha Medical Corporation has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum amid recent market fluctuations. The stock’s current price stands at ₹520.60, down from the previous close of ₹548.40, marking a day change of -5.07%. This movement occurs within a broader context of mixed technical signals and evolving market dynamics.

View All News